Synergistic composition for modulating activity of substrate analogs for NAD+, NADP+, NADH+ or NADPH dependent enzymes and process thereof

Details for Australian Patent Application No. 2007251900 (hide)

Owner National Institute of Immunology Indian Institute of Science

Inventors Parasuraman, Prasanna; Surolia, Namita; Surolia, Avadhesha; Kumar, Gyanendra; Sharma, Shailendra K.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2007251900

Priority 2726/DEL/06 20.12.06 IN

Filing date 20 December 2007

Wipo publication date 10 July 2008

International Classifications

A61K 31/352 (2006.01) - condensed with carbocyclic rings, e.g. cannabinols, methantheline

A61K 31/09 (2006.01)

A61K 31/353 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/06 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 33/06 (2006.01) Antiparasitic agents

Event Publications

17 January 2008 Complete Application Filed

  Priority application(s): 2726/DEL/06 20.12.06 IN

10 July 2008 Application Open to Public Inspection

  Published as AU-A-2007251900

16 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007251901-Use of S-10 hydroxy-10, 11-dihydro-carbamazepine for the treatment of anxiety and bipolar disorders

2007251899-Compositions and methods for modulation of vascular structure and/or function